Alcidion Group (ALC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Nov, 2026Opening remarks and agenda
Virtual AGM opened at 4:00 p.m. AEDT after quorum confirmation, with an acknowledgement of Traditional Custodians; shareholders could watch, ask questions and vote.
Agenda covered the Chair’s address, AGM presentation, formal business, voting and general questions; the annual report was taken as read.
Financial performance review
FY26 revenue was AUD 51.6m, up 27%; ARR was AUD 38.3m, up 34%, including AUD 3.6m from Kyra.
Underlying EBITDA was AUD 6.8m, up 34%; reported EBITDA was AUD 6.2m, up 28%; operating cash flow was AUD 6.8m, up 19%, and NPAT was positive for a second consecutive year.
Record TCV of AUD 78.5m was signed, up 6%, with 79% from new contract sales; year-end cash was AUD 20.6m and the balance sheet was debt-free.
At 30 September 2026, FY27 contracted and renewal revenue expected to be recognised was AUD 50.0m, up 38% YoY; revenue and underlying EBITDA guidance remained above FY26.
Board and executive committee updates
Rebecca Wilson served as Non-executive Chair; Kate Quirke as Group Managing Director and CEO; Daniel Sharp, Andrew Way and William Smart as Non-executive Directors.
Rebecca Wilson was considered for re-election after retirement by rotation; she thanked shareholders and cited stronger operations and a more mature financial profile.
The Chair thanked CEO Kate Quirke, the senior leadership team and staff for FY26 performance.
Latest events from Alcidion Group
- Contracted revenue rose 38% YoY as NCA expanded Miya and new patient administration launched.ALC
Trading update - Record FY26 growth, strong recurring base, and Kyra acquisition drive positive FY27 outlook.ALC
H2 2026 - Record cash flow, major contracts, and Kyra acquisition drive strong growth and outlook.ALC
Q4 2026 - H1 FY26 revenue up 44% and EBITDA up 675%, driven by major contract wins and expansions.ALC
H1 2026 - Record revenue, platform expansion, and key resolutions highlight strong FY2025 performance.ALC
AGM 2025 - Record revenue, 31% ARR growth, and major UK contracts drive strong FY26 outlook.ALC
H2 2025 - Revenue down 8%, recurring revenue 74%, cost cuts drive improved H2 EBITDA and cash flow.ALC
H2 2024 - Record cash receipts, cost savings, and major contracts drive strong FY24 performance.ALC
Q4 2024 - Record new contracts and improved EBITDA drive strong FY25 outlook and profitability.ALC
H1 2025